Biology of Blood and Marrow Transplantation
Volume 17, Issue 2 , Pages 205-213 , February 2011

Mycophenolic Acid Inhibits Natural Killer Cell Proliferation and Cytotoxic Function: A Possible Disadvantage of Including Mycophenolate Mofetil in the Graft-Versus-Host Disease Prophylaxis Regimen

Received 20 May 2010 ,Accepted 16 August 2010.

References 

  1. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187–376
  2. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–2100
  3. Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94:333–339
  4. Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood. 2007;110:433–440
  5. Davies SM, Ruggieri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants: killer immunoglobulin–like receptor. Blood. 2002;100:3825–3827
  6. Farag SS, Bacigalupo A, Eapen M, et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry. Biol Blood Marrow Transplant. 2006;12:876–884
  7. Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood. 2003;102:814–819
  8. Wang H, Grzywacz B, Sukovich D, et al. The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood. 2007;110:1530–1539
  9. Nakao S, Takami A, Takamatsu H, et al. Isolation of a T-cell clone showing HLA-DRB1∗0405–restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia. Blood. 1997;89:3691–3699
  10. Quemeneur L, Flacher M, Gerland LM, et al. Mycophenolic acid inhibits IL-2–dependent T cell proliferation, but not IL-2–dependent survival and sensitization to apoptosis. J Immunol. 2002;169:2747–2755
  11. Espinoza JL, Takamatsu H, Lu X, et al. Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1/2-dependent pathway. Int Immunol. 2009;21:913–923
  12. Kagawa Y, Sawada J, Yamada S, et al. Relationship between development of nephrotoxicity and blood concentration of cyclosporine A in bone marrow transplant recipients who received the continuous intravenous infusion. Biol Pharm Bull. 2003;26:1115–1119
  13. Uberti JP, Cronin S, Ratanatharathorn V. Optimum use of tacrolimus in the prophylaxis of graft-versus-host disease. BioDrugs. 1999;11:343–358
  14. Bonini A, Bandini G, Cirio TM, et al. Methotrexate and delayed engraftment in allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995;16:729–730
  15. Giaccone L, McCune JS, Maris MB, et al. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood. 2005;106:4381–4388
  16. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer cell subsets. Trends Immunol. 2001;22:633–640
  17. Eugui EM, Almquist SJ, Muller CD, et al. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol. 1991;33:161–173
  18. Eugui EM, Mirkovich A, Allison AC. Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol. 1991;33:175–183
  19. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9:1149–1163
  20. Zhang S, Lawless VA, Kaplan MH. Cytokine-stimulated T lymphocyte proliferation is regulated by p27Kip1. J Immunol. 2000;165:6270–6277
  21. Kawada M, Yamagoe S, Murakami Y, et al. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene. 1997;15:629–637
  22. Laliberte J, Yee A, Xiong Y, et al. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood. 1998;91:2896–2904
  23. Nash RA, Johnston L, Parker P, et al. A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005;11:495–505
  24. Barker JN, Weisdorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915–1919
  25. De Maria A, Fogli M, Costa P, et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol. 2003;33:2410–2418
  26. Fairbanks LD, Bofill M, Ruckemann K, et al. Importance of ribonucleotide availability to proliferating T lymphocytes from healthy humans: disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. J Biol Chem. 1995;270:29682–29689
  27. Dayton JS, Lindsten T, Thompson CB, et al. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression. J Immunol. 1994;152:984–991
  28. Carr SF, Papp E, Wu JC, et al. Characterization of human type I and type II IMP dehydrogenases. J Biol Chem. 1993;268:27286–27290
  29. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47:85–118
  30. Kwon TK, Buchholz MA, Ponsalle P, et al. The regulation of p27Kip1 expression following the polyclonal activation of murine G0 T cells. J Immunol. 1997;158:5642–5648
  31. Nourse J, Firpo E, Flanagan WM, et al. Interleukin-2–mediated elimination of the p27Kip1 cyclin–dependent kinase inhibitor prevented by rapamycin. Nature. 1994;372:570–573
  32. Chen G, Wu DP, Yang MZ, et al. The effects of rapamune on NK cell post–bone marrow transplantation in mice. [abstract] Blood. 2007;110:abstract 4858
  33. Dunbar EM, Buzzeo MP, Levine JB, et al. The relationship between circulating natural killer cells after reduced-intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica. 2008;93:1852–1858
  34. Willemze R, Rodrigues CA, Labopin M, et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia. 2009;23:492–500
  35. Brunstein CG, Wagner JE, Weisdorf DJ, et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood. 2009;113:5628–5634

 Financial disclosure: See Acknowledgments on page 212.

PII: S1083-8791(10)00353-8

doi: 10.1016/j.bbmt.2010.08.014

Biology of Blood and Marrow Transplantation
Volume 17, Issue 2 , Pages 205-213 , February 2011

Article Tools

* Image Usage & Resolution